HRMY Q2 2020 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$38M

Gross Profit

$32M83.0% margin

Operating Income

$7M19.2% margin

Net Income

-$27,000-0.1% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+91.6%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$5M

Stock-Based Comp.

$461,000

Balance Sheet

Total Assets

$169M

Total Liabilities

$218M

Stockholders' Equity

-$49M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$0	—
Gross Profit	$32M	$0	—
Operating Income	$7M	-$19M	+137.9%
Net Income	-$27,000	-$21M	+99.9%